Lineage Cell Therapeutics, Inc. (LCTX) has a market capitalization of $396.05M and trades at $1.59. The 52-week range is 0.37-2.09.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.7, Earnings Per Share (EPS) of $-0.28, annual revenue of $14.56M.
The stock has a beta of 1.80, operates in the Healthcare sector.
